474 related articles for article (PubMed ID: 17634428)
1. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
2. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
3. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
5. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D
BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
8. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
[TBL] [Abstract][Full Text] [Related]
9. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
[TBL] [Abstract][Full Text] [Related]
10. A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene.
Zhang J; Yu J; Gu J; Gao BM; Zhao YJ; Wang P; Zhang HY; De Zhu J
Cell Res; 2004 Aug; 14(4):283-94. PubMed ID: 15353125
[TBL] [Abstract][Full Text] [Related]
11. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
12. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
Fujita N; Shimotake N; Ohki I; Chiba T; Saya H; Shirakawa M; Nakao M
Mol Cell Biol; 2000 Jul; 20(14):5107-18. PubMed ID: 10866667
[TBL] [Abstract][Full Text] [Related]
16. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
Qiu G; Fang J; He Y
Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
Yu F; Zingler N; Schumann G; Strätling WH
Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
[TBL] [Abstract][Full Text] [Related]
18. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
19. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin.
Watanabe S; Ichimura T; Fujita N; Tsuruzoe S; Ohki I; Shirakawa M; Kawasuji M; Nakao M
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12859-64. PubMed ID: 14555760
[TBL] [Abstract][Full Text] [Related]
20. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]